suziemarshall

9 POSTS 0 COMMENTS

Improving cardiac resynchronisation therapy

Jagmeet Singh is the founding director of the Resynchronisation and Advanced Cardiac Therapeutics Program. Singh is the principal investigator for the Personalised CRT-MPP Post-Approval...

Results of head-to-head comparison of patch-based arrhythmia monitors announced

The American Heart Journal has published the results of a head-to-head comparison of two patch-based arrhythmia monitoring systems. The study, "Comparison of two ambulatory...

AI used to detect ‘invisible’ heart condition

Investigators from the Mayo Clinic and AliveCor demonstrated that a trained artificial intelligence network can help identify people with increased risks of arrhythmias...

Late-breaking data highlight reduction in rate of inappropriate shocks with sensing...

The SMART Pass sensing filter (Boston Scientific), when in patients implanted with the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) System, successfully reduces inappropriate shocks. This...

Cardiac contractility modulation in heart failure treatment is safe

Cardiac contractility modulation (CCM) in heart failure is safe, the results from the FIX-HF-5C randomised controlled trial demonstrate, with all primary and secondary safety...

Late-breaking presentation at Heart Rhythm 2018 shows potential for more patients...

An investigational algorithm, utilising the accelerometer signal in the Micra Transcatheter Pacing System (TPS) (Medtronic) may restore AV synchrony, improving cardiac function in patients...

Study to evaluate novel high power, short duration modality for treatment...

The first patient has been enrolled and treated in the QDOT AF study (Biosense Webster). The study will evaluate the delivery of high...

Advisor HD Grid mapping catheter, sensor enabled, gains FDA clearance

Abbott has announced US Food and Drug Administration (FDA) clearance of the Advisor HD Grid mapping catheter, sensor enabled. Advisor HD Grid employs a new...

FDA releases final rule on acceptance of data from clinical investigations...

The Food and Drug Administration (FDA) has today issued the final rule on “human subject protection; acceptance of data from clinical investigations for medical...